These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19190346)

  • 1. Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.
    Ramachandran K; Gopisetty G; Gordian E; Navarro L; Hader C; Reis IM; Schulz WA; Singal R
    Cancer Res; 2009 Feb; 69(4):1527-35. PubMed ID: 19190346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neoplastic properties of hydralazine in prostate cancer.
    Graça I; Sousa EJ; Costa-Pinheiro P; Vieira FQ; Torres-Ferreira J; Martins MG; Henrique R; Jerónimo C
    Oncotarget; 2014 Aug; 5(15):5950-64. PubMed ID: 24797896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells.
    Paxson AI; Chang LH; Gard JMC; Harryman WL; Nelson CS; Salmon SB; Marr KD; Wachsmuth LM; Ramanathan A; Ran J; Kapoor A; Marugan JJ; Henderson MJ; Sanchez TW; Cress AE
    Front Cell Dev Biol; 2023; 11():1285372. PubMed ID: 38046670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology.
    Nejati-Koshki K; Roberts CT; Babaei G; Rastegar M
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer.
    Wang X; Hao Y; Chen J; Ding P; Lv X; Zhou D; Li L; Li L; Xu Y; Zhu Y; Zhang W; Chen L; Liao T; He X; Ji QH; Hu W
    Cell Death Dis; 2023 Jun; 14(6):351. PubMed ID: 37291119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms within DIO2 and GADD45A genes increase the risk of liver disease progression in chronic hepatitis b carriers.
    Rybicka M; Verrier ER; Baumert TF; Bielawski KP
    Sci Rep; 2023 Apr; 13(1):6124. PubMed ID: 37059745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles for GADD45 in Development and Cancer.
    Patel K; Murray MG; Whelan KA
    Adv Exp Med Biol; 2022; 1360():23-39. PubMed ID: 35505160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinapine Thiocyanate Inhibits the Proliferation and Mobility of Pancreatic Cancer Cells by Up-Regulating GADD45A.
    Wang J; Zeng Z; Lei S; Han J; Liao S; Zhang J; Wang L; Dong Y; Li H; Chen T
    J Cancer; 2022; 13(4):1229-1240. PubMed ID: 35281859
    [No Abstract]   [Full Text] [Related]  

  • 9. tRNA
    Yang C; Lee M; Song G; Lim W
    Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33406670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors.
    Romero-Garcia S; Prado-Garcia H; Carlos-Reyes A
    Front Oncol; 2020; 10():1152. PubMed ID: 32850327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells.
    Sennoune SR; Nelius T; Jarvis C; Pruitt K; Kottapalli KR; Filleur S
    PLoS One; 2020; 15(6):e0234078. PubMed ID: 32484838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
    Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
    Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MeCP2 Promotes Colorectal Cancer Metastasis by Modulating ZEB1 Transcription.
    Luo D; Ge W
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32210086
    [No Abstract]   [Full Text] [Related]  

  • 14. GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer.
    Han N; Yuan F; Xian P; Liu N; Liu J; Zhang H; Zhang H; Yao K; Yuan G
    Onco Targets Ther; 2019; 12():7591-7599. PubMed ID: 31571910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma.
    Li T; Xu L; Teng J; Ma Y; Liu W; Wang Y; Chi X; Shao S; Dong Y; Zhan Q; Liu X
    Dig Dis Sci; 2020 Apr; 65(4):1032-1041. PubMed ID: 31562612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma.
    Bian E; Chen X; Xu Y; Ji X; Cheng M; Wang H; Fang Z; Zhao B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):366. PubMed ID: 31429770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation.
    Varnai R; Koskinen LM; Mäntylä LE; Szabo I; FitzGerald LM; Sipeky C
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31398933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GADD45α-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status.
    Shi Q; Sutariya V; Varghese Gupta S; Bhatia D
    Onco Targets Ther; 2019; 12():3161-3170. PubMed ID: 31114253
    [No Abstract]   [Full Text] [Related]  

  • 19. Cold Physical Plasma Modulates p53 and Mitogen-Activated Protein Kinase Signaling in Keratinocytes.
    Schmidt A; Bekeschus S; Jarick K; Hasse S; von Woedtke T; Wende K
    Oxid Med Cell Longev; 2019; 2019():7017363. PubMed ID: 30733851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines.
    Machioka K; Izumi K; Kadono Y; Iwamoto H; Naito R; Makino T; Kadomoto S; Natsagdorj A; Keller ET; Zhang J; Mizokami A
    Oncotarget; 2018 Mar; 9(22):16185-16196. PubMed ID: 29662635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.